As of April 1, 2026, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.

Here's the latest list of major overbought players in this sector.

Alkermes Plc (NASDAQ:ALKS)

  • On March 24, Piper Sandler analyst David Amsellem maintained Alkermes with an Overweight rating and lowered the price target from $45 to $43. The company's stock gained around 23% over the past five days and has a 52-week high of $36.32.
  • RSI Value: 82.3                                
  • ALKS Price Action: Shares of Alkermes gained 17.3% to close at $35.36 on Tuesday.
  • Edge Stock Ratings: 78.64 Momentum score with Value at 63.98.

Assertio Holdings Inc (NASDAQ:ASRT)

  • On March 16, Assertio Holdings posted mixed quarterly results. Mark Reisenauer, Chief Executive Officer, said, “Our core asset, Rolvedon, continues to represent a meaningful revenue opportunity, as reflected in both our 2025 results and 2026 outlook, and our strong commercial infrastructure and market access capabilities provide a platform to expand and build an oncology portfolio in a disciplined way.” The company's stock gained around 62% over the past month and has a 52-week high of $20.45.
  • RSI Value: 81.4
  • ASRT Price Action: Shares of Assertio rose 4.3% to close at $19.06 on Tuesday.

Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and see how they compare.

Photo via Shutterstock